Astex Pharmaceuticals Announces Initiation of AT13387 Phase 2 Study in Non-Small Cell Lung Cancer 24 October 2012/in 2012, News /by webadminAstex Pharmaceuticals Announces Initiation of AT13387 Phase 2 Study in Non-Small Cell Lung Cancer /wp-content/uploads/2016/11/logo.png 0 0 webadmin /wp-content/uploads/2016/11/logo.png webadmin2012-10-24 08:56:342016-12-01 16:41:32Astex Pharmaceuticals Announces Initiation of AT13387 Phase 2 Study in Non-Small Cell Lung Cancer
